Treatment options for thyroid cancer: an interview with Kate Newbold

Endocrine For clinicians For patients How I treat... Targeted therapies
thyroid cancer

Find out about current treatment options for thyroid cancer, such as the recent approval of selpercatinib for patients with an alteration in the RET gene, in this interview with Kate Newbold who is a clinical oncologist consultant at The Royal Marsden Hospital in London (UK). To listen to the podcast, fill in the short form below.

Visit the full In Focus page here.